NKTR earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -8.23. Updated 2026-07-23.
Nektar Therapeutics (NKTR) Research Hub
Nektar Therapeutics (NKTR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 37.45 USD (+0.62%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.23, market cap 1.35B. This hub links to the full technical, earnings and options research available for NKTR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 37.45 USD (+0.62%) |
| 52-week range | 35.61 USD – 77.76 USD |
| Trend regime | Range |
| 14-day RSI | 41.7 (Bearish) |
| Trailing P/E | -8.23 |
| Market cap | 1.35B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for NKTR
Covered Call on NKTR: how it works, illustrative setup around the real 37.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NKTR: how it works, illustrative setup around the real 37.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NKTR: how it works, illustrative setup around the real 37.45 USD price, max profit/loss, breakeven and when to use it. Educational.
NKTR technical analysis: range, last 37.45 USD, RSI 41.7, 52w range 35.61 USD–77.76 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NKTR in?
Nektar Therapeutics (NKTR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NKTR in an uptrend or downtrend?
As of 2026-10-26, NKTR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NKTR's trailing P/E ratio?
NKTR's trailing P/E is -8.23, with a market cap of 1.35B. See the earnings research page for full valuation detail.
When does NKTR next report earnings?
NKTR is next scheduled to report earnings on 2026-08-06.